Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy? Mamtani A, Grabenstetter A, Sevilimedu V, Morrow M, et al. Breast Cancer Res Treat 2023;197:417-423.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mamtani A, Grabenstetter A, Sevilimedu V, Morrow M, et al. Do non-classic invasive lobular carcinomas derive a benefit from neoadjuvant chemotherapy? Breast Cancer Res Treat 2023;197:417-423.
PMID: 36394689